Helena Jerkić

Helena Jerkić

Auto-generated profile, based on publicly available information

Helena Jerkić

Division of Cardiology, University Hospital Merkur

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in Acta Clinica Belgica
Verified
Journal Article
Closed access
IJIvana Jurin
Ivana Jurin
IHIrzal Hadžibegović
Irzal Hadžibegović
IDIvan Durlen
Ivan Durlen
SJSandra Jaksic Jurinjak
Sandra Jaksic Jurinjak
DMDomagoj Mišković
Domagoj Mišković
TLTomislav Letilović
Tomislav Letilović
Objective: Stratifying patients with paroxysmal or short-term persistent atrial fibrillation (AF) who are at greater risk of developing permanent AF is challenging. Aim of our prospective study was to evaluate association of laboratory parameters (biochemistry and complete blood count (CBC)) together with standard demographic, clinical and echocardiography parameters, with AF progression. Methods: We prospectively recruited 579 patients with AF and divided them into two groups at index hospitalization: paroxysmal or persistent (non-permanent AF), and long-term persistent or permanent AF patients (permanent AF). Clinical, echocardiographic, and relevant CBC parameters were collected. Non-permanent AF patients were selected for follow-up, with a median follow-up time of 21 months. Endpoint was progression to permanent AF. Results: Out of 409 patients with non-permanent AF, 109 (26.6%) progressed within follow-up. In a multivariate Cox regression model only increased left atrium (LA) diameter (HR 2.16, 95% CI 1.20–3.87, p = 0.010), and increased red cell distribution width (RDW; HR 1.19, 95% CI 1.03–1.39, p = 0.022) showed significant independent association with progression. There were 221/409 patients with both LA ≤45 mm and RDW level ≤14.5% who progressed at a rate of only 17.6%, and showed relative risk of AF progression of 0.47 (95% CI 0.34–0.67; p < 0,001). Conclusion: Together with LA size, RDW was independently associated with AF progression. Patients with both LA size ≤45 mm and RDW level ≤14.5% are most probably the best candidates for rhythm control strategies.

21 May 2021 in Medicine
Verified
Journal Article
Open access
ZSZrinka Sertić
Zrinka Sertić
TLTomislav Letilović
Tomislav Letilović
TKTajana Filipec Kanižaj
Tajana Filipec Kanižaj
MKMladen Knotek
Mladen Knotek
IHIrzal Hadžibegović
Irzal Hadžibegović
HJHelena Jerkić
Helena Jerkić
Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.


1 October 2017 in Cardiologia Croatica
Verified
Journal Article
Closed access
BLBruno Lovreković
Bruno Lovreković
MSMario Stipinović
Mario Stipinović
TLTomislav Letilović
Tomislav Letilović
DPDarko Počanić
Darko Počanić
NŠNjetočka Gredelj Šimec
Njetočka Gredelj Šimec
HJHelena Jerkić
Helena Jerkić

1 October 2017 in Cardiologia Croatica
Verified
Journal Article
Closed access
VRVedran Radonić
Vedran Radonić
DKDamir Kozmar
Damir Kozmar
DPDarko Počanić
Darko Počanić
HJHelena Jerkić
Helena Jerkić
IBIvan Bohaček
Ivan Bohaček
TLTomislav Letilović
Tomislav Letilović

1 November 2016 in Cardiologia Croatica
Verified
Journal Article
Closed access
MMMatija Marković
Matija Marković
EKEna Kurtić
Ena Kurtić
DPDarko Počanić
Darko Počanić
MSMario Stipinović
Mario Stipinović
SKStjepan Kranjčević
Stjepan Kranjčević
IMIvica Premužić Meštrović
Ivica Premužić Meštrović